Keysight’s beat is less about a cyclical snapback than a mix reset the Street is still discounting
Keysight Technologies, Inc. cleared Q1 expectations on both revenue and EPS, but the investable point is that acquisition mix, software/services density, and orders are pulling the model toward a higher-margin profile before the late-2026 synergy benefit arrives. The market had priced a recovery; the surprise was that revenue, orders, and Q2 guidance now make that recovery less dependent on a broad industrial rebound and more tied to specific communications, semiconductor, and test complexity demand.
The print changes the debate because Keysight did not merely beat a low bar: it beat the Street on Q1 revenue by +3.9% and EPS by +8.5%, then guided Q2 revenue to $1.690 billion to $1.710 billion and Q2 EPS to $2.27 to $2.33. What was priced in was a continuation of the measured recovery visible through Q4 FY2025 revenue of $1,419.0 million and Q1 FY2026 Street revenue expectations of $1,540.4 million. What surprised was the breadth and quality of the upside: actual Q1 revenue was $1,600.0 million, orders were $1.645 billion, and management framed Q2 around a guide of $1.7 billion rather than a one-quarter pull-forward. The variant perception is that investors may still be treating Keysight as a late-cycle test-and-measurement recovery stock, when this print points to a more durable mix upgrade. Acquisitions added 8 points to reported growth, currency added 1 point, software and services reached approximately 40% of revenue, and annual recurring revenue was 29% of total mix. That combination matters because the margin debate has been anchored on whether growth returns; the better question is whether the returned growth is coming in with structurally higher gross margin and operating leverage.
The first distinction for PMs is the one between what consensus expected and what the company actually delivered on the Street-comparison basis. EPS of $2.17 versus $2.00 was an +8.5% surprise, while revenue of $1,600.0 million versus $1,540.4 million was a +3.9% surprise. Those are the numbers that define the beat. The company’s own call basis adds texture rather than replacing that comparison: Neil Dougherty said, “First quarter total company revenue of $1.600 billion was up 23% on a reported basis with acquisitions adding 8 points and currency 1 point.” That wording is important because it separates the headline from the underlying bridge. The market can dismiss acquired revenue if it does not carry margin or if it masks core weakness; here, orders were $1.645 billion, up 30% on a reported basis and up 22% on a core basis, so the acquisition overlay is not the whole story. The core signal is that demand is recovering faster than Street revenue assumptions, while the acquisition signal is that the company has changed the mix of the revenue base.
That revenue trajectory becomes more compelling when placed against the prior trough, because the sequential pattern has moved from stabilization to acceleration. Revenue fell from $1,390.0 million in Q2 FY2023 to $1,216.0 million in Q2 FY2024, then recovered through $1,306.0 million in Q2 FY2025, $1,352.0 million in Q3 FY2025, and $1,419.0 million in Q4 FY2025 before reaching $1,600.0 million in Q1 FY2026. The reported YoY growth rate has moved from +3.1% in Q1 FY2025 to +7.4% in Q2 FY2025, +11.1% in Q3 FY2025, +10.3% in Q4 FY2025, and +23.3% in Q1 FY2026. That is why the print was not simply a beat against $1,540.4 million; it was the first quarter in this dataset where growth clearly stepped beyond recovery math and into a new run-rate discussion. The market was prepared for improvement after four consecutive quarters of YoY growth; it was less prepared for a Q1 revenue base of $1,600.0 million paired with a Q2 guide whose midpoint implies 30% year-over-year growth, per management’s call language.
The margin story explains why the revenue beat should not be faded as low-quality volume. The quarterly history shows gross margin slipping from 65.4% in Q2 FY2023 to 61.2% in Q4 FY2025 before improving to 62.2% in Q1 FY2026, while management’s call basis put Q1 gross margin at 66.7%, up 90 basis points, driven by favorable product mix and higher gross margin revenues from recent acquisitions. The reporting-basis difference matters, so the right conclusion is not to collapse those numbers into one margin series. The right conclusion is that both bases now point away from the bear case: the history basis turned up from 61.2% to 62.2%, and the company’s own operating narrative points to mix helping, not hurting. Operating expenses were $628 million, and operating margin was 27.4%, up 20 basis points. More important, the core business delivered operating margin of 28.9%, up 170 basis points year-over-year as a result of 41% core operating leverage. If investors were waiting for revenue growth to convert into profit growth, the conversion evidence arrived in the same quarter as the top-line beat.
That conversion evidence is strongest in Communications Solutions Group, which is the piece most likely to reshape expectations for semiconductor and AI infrastructure exposure. CSG generated $1.124 billion in revenue, up 27% reported and up 16% core, with gross margin of 68.5% and operating margin of 27.5%. Within CSG, commercial communications generated $758 million, up 33%, with growth in wireless and wireline; aerospace, defense and government generated $366 million, an increase of 18%. The implication is that Keysight’s recovery is not confined to one end market. Commercial communications is carrying the highest growth within the disclosed CSG pieces at up 33%, but aerospace, defense and government at up 18% adds a less consumer-dependent leg. For NVIDIA, Qualcomm, and Broadcom, all identified customers for test and measurement and parametric testers, the read-through is not that their revenue should be marked up from this print alone; it is that their lab, validation, and parametric test intensity is showing up in Keysight orders of $1.645 billion and reported CSG revenue growth of 27%. The magnitude matters: CSG’s $1.124 billion is the majority of the disclosed segment revenue base, and its commercial communications component alone was $758 million, so this is a meaningful signal for wireless, wireline, and high-complexity connectivity test demand.
The EISG result broadens that read-through into semiconductors and automotive rather than leaving the thesis dependent on communications. Electronic Industrial Solutions Group generated $476 million in revenue, an increase of 15%, with growth across general electronics, semiconductors, and automotive, and delivered gross margin of 62.4% and operating margin of 27.2%. That is not a small, low-margin appendage: the operating margin of 27.2% is close to CSG’s 27.5%, while its exposure set directly includes semiconductors and automotive. For Qualcomm and Broadcom, the implication is that broader electronics and semiconductor test demand is recovering alongside commercial communications, not lagging it. For NVIDIA, the explicit data-pack tie is test and measurement and parametric testers, and the relevant evidence is not an AI revenue number at Keysight, because none is given; it is the combination of EISG growth of 15%, CSG core growth of 16%, and orders up 22% on a core basis. The second-order takeaway is that advanced customers are likely still funding test capacity and validation capability even as cycle debates remain uneven across semis.
The peer frame supports the same point but also caps how far we should stretch it. In the Test_Assembly peer set, ATEYY reported revenue YoY of +43.8% with gross margin of 67.4%, DSCSY reported revenue YoY of +12.3% with gross margin of 70.8%, and 6871.T reported revenue YoY of +48.3% with gross margin of 47.3%. Keysight’s Q1 FY2026 revenue YoY of +23.3% and quarterly-history gross margin of 62.2% sit between the fastest-growth Japanese test names and the highest-gross-margin peer in the table. On the company’s call basis, Q1 gross margin was 66.7%, closer to ATEYY’s 67.4% than to the lower-margin assembly equipment names such as 6315.T at 36.2% or 6125.T at 25.4%. The comparison argues against viewing Keysight as merely a slower, diversified instrument vendor. It is not printing the +43.8% or +48.3% YoY growth seen at the most cyclically levered peers, but it is pairing +23.3% revenue YoY with software and services at approximately 40% of revenue and annual recurring revenue at 29% of total mix. That mix is the part the market may be undercapitalizing.
The capital allocation and balance-sheet details reinforce the mix thesis because management is not asking investors to wait for a distant synergy story without current cash generation. Keysight ended the quarter with approximately $2.200 billion in cash and cash equivalents, generated cash flow from operations of $441 million, and generated free cash flow of $407 million. It repurchased approximately 420,000 shares at an average price of approximately $207 for total consideration of $87 million, and Satish Dhanasekaran pointed to a $1.5 billion stock buyback authorization. The buyback is not the core reason to own the stock after this print, but it helps underwrite the downside while the company integrates acquired revenue and waits for synergy realization. Management’s acquisition revenue expectation for fiscal 2026 is $375 million, and the synergy target is more than $100 million in run rate cost synergies and other operational efficiencies, with realization heavily weighted to late in 2026 given the ERP migration timeline. The timing is the key risk and opportunity: Q1 already shows mix helping gross margin, while the cost synergy dollars are not yet the primary source of upside.
That same timing point makes the Q2 guide the near-term battleground. Dougherty’s guide was explicit: “For the second quarter of 2026, we expect revenue in the range of $1.690 billion to $1.710 billion, representing 30% year-over-year growth at the midpoint.” He also guided EPS to $2.27 to $2.33, representing 35% year-over-year growth at the midpoint. The wording around orders matters more than usual because it tells investors not to overreact if book-to-bill optics look less spectacular in Q2. Dougherty said the timing of some bigger deals shipping in Q2 is “likely going to kind of bring orders and revenue close together, either side of one.” That is a real hedge, and it should be treated as such: Q1 orders of $1.645 billion were ahead of revenue of $1.600 billion, but management is preparing investors for Q2 orders and revenue to converge around the shipment of larger deals. The confirmation is not another large spread between orders and revenue; the confirmation is revenue in the $1.690 billion to $1.710 billion range with EPS in the $2.27 to $2.33 range and no deterioration in the core growth narrative.
The call-delivery data mostly supports management’s confidence, but it also identifies where PMs should be skeptical. The tone history shows Q2 FY2026 sentiment at 0.48 versus 0.43 in Q1 FY2026, guidance_tone at 0.66 versus 0.60, and tone_confidence at 0.31 versus 0.27. Prepared_sentiment improved sharply to 0.80 from 0.03, while uncertainty fell to 37.1 from 46.4 and qa_evasiveness fell to -1.8 from 46.9. That is a cleaner delivery than Q1 FY2026 and a material reversal from the prior call’s elevated qa_evasiveness. The conflicting note is qa_sentiment, which fell to 0.25 from 0.47, and ai_optimism, which fell to 0.38 from 0.43. That conflict matters because prepared remarks were much more positive, but the Q&A tone did not improve with the same force. The right interpretation is not that management lacks confidence; it is that management is confident on the guide and the synergy plan while still careful on the timing of larger deals and order-revenue alignment.
The stock debate after this print should therefore shift from “is demand recovering?” to “what multiple should be paid for a test platform with Q1 orders up 30% reported, CSG gross margin of 68.5%, EISG operating margin of 27.2%, software and services at approximately 40% of revenue, and annual recurring revenue at 29% of mix?” The market had enough evidence to expect cyclical repair after Q4 FY2025 revenue of $1,419.0 million and Q1 FY2026 consensus revenue of $1,540.4 million. It did not have enough evidence to price a model where the acquired assets add 8 points to reported growth, core orders grow 22%, and management keeps the $375 million fiscal 2026 acquisition revenue target while still pointing to more than $100 million in run rate cost synergies later in 2026. That does not eliminate integration risk, particularly with synergy realization heavily weighted to late in 2026 because of ERP migration. But it does make the current quarter more than a demand beat. It is the first print in this sequence where growth, mix, cash flow, and guidance all argue in the same direction.
What to watch next is precise. For Q2 FY2026, the thesis holds if revenue lands inside or above $1.690 billion to $1.710 billion, EPS lands inside or above $2.27 to $2.33, and orders stay close to revenue as management previewed, rather than falling in a way that breaks the “either side of one” framing. Segment confirmation would be CSG sustaining growth near the Q1 disclosed 27% reported and 16% core rates, with commercial communications not abruptly fading from the $758 million base, and EISG continuing to show growth across general electronics, semiconductors, and automotive from the $476 million base. Margin confirmation would be Q2 gross margin holding the improvement signaled by Q1 call-basis gross margin of 66.7% and segment gross margins of 68.5% in CSG and 62.4% in EISG, while operating expenses do not move materially away from the $628 million Q1 baseline without a matching revenue payoff. The break points are equally clear: revenue below $1.690 billion, EPS below $2.27, any reduction to the $375 million fiscal 2026 acquisition revenue expectation, or slippage in the more than $100 million synergy target tied to late-2026 ERP migration would turn this from a mix-upgrade story back into a cyclical recovery with integration risk.